Maglione et al. measured serum BCMA levels in 165 patients and discovered that serum BCMA was significantly reduced in severe primary antibody deficiencies such as XLA and CVID, compared with less profound antibody deficiencies such as selective IgA or mild IgG deficiency [78]. The gene discussed is CD79A; the disease is Bruton-type agammaglobulinemia.